Legend Biotech’s $403 Million Shares Offering

Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation.Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000 American…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now